KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $199.5 million.

  • Edwards Lifesciences' Receivables - Other rose 10890.05% to $199.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.5 million, marking a year-over-year increase of 10890.05%. This contributed to the annual value of $118.3 million for FY2024, which is 9142.39% up from last year.
  • Edwards Lifesciences' Receivables - Other amounted to $199.5 million in Q3 2025, which was up 10890.05% from $205.6 million recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Receivables - Other peaked at $205.6 million during Q2 2025, and registered a low of $42.8 million during Q2 2022.
  • In the last 5 years, Edwards Lifesciences' Receivables - Other had a median value of $62.3 million in 2023 and averaged $80.8 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first tumbled by 4786.89% in 2021, then soared by 26648.84% in 2025.
  • Edwards Lifesciences' Receivables - Other (Quarter) stood at $82.7 million in 2021, then crashed by 32.16% to $56.1 million in 2022, then rose by 0.89% to $56.6 million in 2023, then surged by 109.01% to $118.3 million in 2024, then soared by 68.64% to $199.5 million in 2025.
  • Its last three reported values are $199.5 million in Q3 2025, $205.6 million for Q2 2025, and $82.7 million during Q1 2025.